The current PE ratio for Sotera Health stock as of Jun 3, 2026 is 37.24. This is calculated based on the TTM EPS of $0.41 and the stock price of $15.27 per share. The PE ratio has decreased by 51% from its last 4 quarters average of 75.6.
The average historical PE ratio of Sotera Health for the last five years is 228.1. The current price-to-earnings ratio of 37.24 is 84% less than the historical average. Analyzing the last five years, SHC's PE ratio reached its highest point in the Jun 2021 quarter at 2,423, when the price was $24.23 and the EPS was $0.01. The lowest point was recorded in the Sep 2022 quarter, when it reached 15.86 with a price of $6.82 and an EPS of $0.43.
Maximum annual decrease: -23.59% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 65.33 | -23.59% | $17.64 | $0.27 |
| 2024 | 85.5 | -8.66% | $13.68 | $0.16 |
| 2023 | 93.61 | N/A | $16.85 | $0.18 |
| 2022 | N/A | N/A | $8.33 | -$0.83 |
| 2021 | 57.44 | N/A | $23.55 | $0.41 |
| 2020 | N/A | N/A | $27.44 | -$0.16 |
| 2019 | N/A | N/A | N/A | -$0.09 |
| 2018 | N/A | N/A | N/A | -$0.03 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 34.98 | -46.46% | $14.34 | $0.41 |
| Dec 2025 | 65.33 | -16.94% | $17.64 | $0.27 |
| Sep 2025 | 78.65 | -36.35% | $15.73 | $0.2 |
| Jun 2025 | 123.56 | -4.63% | $11.12 | $0.09 |
| Mar 2025 | 129.56 | 51.53% | $11.66 | $0.09 |
| Dec 2024 | 85.5 | 27.99% | $13.68 | $0.16 |
| Sep 2024 | 66.8 | -21.22% | $16.7 | $0.25 |
| Jun 2024 | 84.79 | 34.14% | $11.87 | $0.14 |
| Mar 2024 | 63.21 | -32.48% | $12.01 | $0.19 |
| Dec 2023 | 93.61 | N/A | $16.85 | $0.18 |
| Sep 2023 | N/A | N/A | $14.98 | -$1.1 |
| Jun 2023 | N/A | N/A | $18.84 | -$0.96 |
| Mar 2023 | N/A | N/A | $17.91 | -$0.93 |
| Dec 2022 | N/A | N/A | $8.33 | -$0.83 |
| Sep 2022 | 15.86 | -64.38% | $6.82 | $0.43 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of SHC is under its 3 and 5-year averages.
With a price to earnings (P/E) of 37.24, SHC stands higher than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 23.02, Sotera Health's price to earnings (P/E) is 62% higher.
SHC's price to earnings ratio is 37.24 as of Jun 3, 2026.
As an average over the last 3 years, SHC stock has a PE ratio of 82.6.
As an average over the last 5 years, SHC stock has a PE ratio of 228.1.
Over the last five years, the Jun 2021 quarter recorded the highest quarterly PE ratio at 2,423.
The current PE ratio of SHC is 84% lower than the 5-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 3, 2026), Sotera Health's share price is $15.27. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.41. Therefore, Sotera Health's price to earnings ratio for today is 37.24. PE RATIO(37.24) = STOCK PRICE($15.27) / TTM EPS($0.41)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.